José Arias Correal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
José Arias Correal has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Juan Carlos Trujillo Cárdenas
Hospital Universitario de la Samaritana
2 shared publications - Alejandra Rojas Ríos
Hospital Universitario de la Samaritana
1 shared publication Alejandro Silva Espinosa
Grupo de Genética Humana Universidad de La Sabana Chía Colombia
1 shared publicationAna M. Santos
Grupo de Espondiloartropatías Rheumatology Department Universidad de La Sabana Chía Colombia
1 shared publication- Carlos Mauricio Calderón-Vargas
Departamento de Medicina Interna, Hospital Universitario de La Samaritana, Bogotá, Colombia
1 shared publication Catalina Villota‐Erazo
Grupo de Espondiloartropatías Rheumatology Department Universidad de La Sabana Chía Colombia
1 shared publication
Latest Publications
- Open Access
- 27 June 2025
- Published by Asociacion Colombiana de Hematologia y Oncologia in Revista Colombiana de Hematología y Oncología
- Vol. 12 (1) , 130-137
Síndrome destructivo de línea media, a propósito de un caso de linfoma extranodal tipo T/NK asociado a infección por virus de Epstein-Barr en un paciente joven
Introduction: Extranodal T/NK lymphoma (ENKEL-NT) nasal type is a rare and aggressive form of non-Hodgkin's lymphoma (NHL) associated with Epstein Barr virus (EBV) infection, characterized by a neoplastic proliferation of the T/NK cell lymphoreticular system. Its incidence is variable, being common in regions such as Asia and Latin America. Clinical case: 30-year-old male patient, with no significant pathological or family history, call center employee, who consulted for involuntary weight loss of 10 kg associated with mass sensation, obstruction in the right nostril and cacosmia. Imaging studies showed a mass with involvement of the midline, subcutaneous cellular tissue, gums and hard palate. A biopsy of the mass was obtained with findings of atypical lymphoid proliferation and necrotic material, positive immunohistochemistry for CD56, CD4, CD2 and CD8 confirming ENKEL-NK nasal type. EBV was confirmed by serology and viral load. Discussion: ENKEL-NT is a tumor of unusual presentation and given its wide range of differential diagnoses can generate difficulties in diagnostic accuracy. Due to its location it can progress from an indolent and self-limited form to a disseminated form that can impact prognosis and management. Its definitive diagnosis is limited to histopathology and in situ hybridization for EBV. Conclusion: ENKEL NT is an unusual and aggressive form of NHL, being a diagnostic challenge due to its wide differential margin. Its histopathologic diagnosis in early stages could have an impact on disease control and survival.
- 27 June 2025
- Published by Asociacion Colombiana de Hematologia y Oncologia in Revista Colombiana de Hematología y Oncología
- Vol. 12 (1) , 130-137
Open AccessSíndrome destructivo de línea media, a propósito de un caso de linfoma extranodal tipo T/NK asociado a infección por virus de Epstein-Barr en un paciente joven
Introduction: Extranodal T/NK lymphoma (ENKEL-NT) nasal type is a rare and aggressive form of non-Hodgkin's lymphoma (NHL) associated with Epstein Barr virus (EBV) infection, characterized by a neoplastic proliferation of the T/NK cell lymphoreticular system. Its incidence is variable, being common in regions such as Asia and Latin America. Clinical case: 30-year-old male patient, with no significant pathological or family history, call center employee, who consulted for involuntary weight loss of 10 kg associated with mass sensation, obstruction in the right nostril and cacosmia. Imaging studies showed a mass with involvement of the midline, subcutaneous cellular tissue, gums and hard palate. A biopsy of the mass was obtained with findings of atypical lymphoid proliferation and necrotic material, positive immunohistochemistry for CD56, CD4, CD2 and CD8 confirming ENKEL-NK nasal type. EBV was confirmed by serology and viral load. Discussion: ENKEL-NT is a tumor of unusual presentation and given its wide range of differential diagnoses can generate difficulties in diagnostic accuracy. Due to its location it can progress from an indolent and self-limited form to a disseminated form that can impact prognosis and management. Its definitive diagnosis is limited to histopathology and in situ hybridization for EBV. Conclusion: ENKEL NT is an unusual and aggressive form of NHL, being a diagnostic challenge due to its wide differential margin. Its histopathologic diagnosis in early stages could have an impact on disease control and survival.
- Open Access
- 3 April 2024
- Published by Asociacion Colombiana de Medicina Interna in Acta Médica Colombiana
- Vol. 49 (3)
Caracterización de la criptococosis meníngea en pacientes no infectados con virus de inmunodeficiencia humana, hospitalizados en una institución de tercer nivel de Bogotá, Colombia
Introducción: La criptococosis es una infección fúngica oportunista relevante, compromete fundamentalmente el sistema nervioso central (SNC) y se relaciona con una alta mortalidad tanto en pacientes seropositivos como negativos. Métodos: Estudio descriptivo, retrospectivo de corte transversal que incluyó historias clínicas de pacientes adultos hospitalizados con diagnóstico de criptococosis meníngea y que cumplieron los criterios de inclusión. Para las variables cuantitativas se calcularon medidas de tendencia central y de dispersión. Las variables cualitativas fueron agrupadas en tablas de frecuencia. Resultados: Muestra de 6 casos homogénea, con misma incidencia entre sexos. El antígeno de Cryptococcus spp en sangre y LCR fue positivo en todos los casos, mientras que la RT PCR fue diagnóstica en 4 pacientes, el cultivo por su parte documentó aislamiento en solo dos casos. La hiperproteinorraquia, pleocitosis, hipoglucorraquia y aumento de la presión de apertura fueron los hallazgos más frecuentes en el examen de líquido cefalorraquídeo. En neuroimágenes solo se evidenciaron lesiones compatibles con la infección en dos pacientes. Conclusiones: La meningitis criptocócica tiene una presentación variable que requiere alta sospecha clínica no únicamente en pacientes seropositivos para VIH, tiene un curso altamente letal. El diagnóstico precisa pruebas microbiológicas o moleculares de buen rendimiento, ampliamente disponibles que siempre deben solicitarse.
- 3 April 2024
- Published by Asociacion Colombiana de Medicina Interna in Acta Médica Colombiana
- Vol. 49 (3)
Open AccessCaracterización de la criptococosis meníngea en pacientes no infectados con virus de inmunodeficiencia humana, hospitalizados en una institución de tercer nivel de Bogotá, Colombia
Introducción: La criptococosis es una infección fúngica oportunista relevante, compromete fundamentalmente el sistema nervioso central (SNC) y se relaciona con una alta mortalidad tanto en pacientes seropositivos como negativos. Métodos: Estudio descriptivo, retrospectivo de corte transversal que incluyó historias clínicas de pacientes adultos hospitalizados con diagnóstico de criptococosis meníngea y que cumplieron los criterios de inclusión. Para las variables cuantitativas se calcularon medidas de tendencia central y de dispersión. Las variables cualitativas fueron agrupadas en tablas de frecuencia. Resultados: Muestra de 6 casos homogénea, con misma incidencia entre sexos. El antígeno de Cryptococcus spp en sangre y LCR fue positivo en todos los casos, mientras que la RT PCR fue diagnóstica en 4 pacientes, el cultivo por su parte documentó aislamiento en solo dos casos. La hiperproteinorraquia, pleocitosis, hipoglucorraquia y aumento de la presión de apertura fueron los hallazgos más frecuentes en el examen de líquido cefalorraquídeo. En neuroimágenes solo se evidenciaron lesiones compatibles con la infección en dos pacientes. Conclusiones: La meningitis criptocócica tiene una presentación variable que requiere alta sospecha clínica no únicamente en pacientes seropositivos para VIH, tiene un curso altamente letal. El diagnóstico precisa pruebas microbiológicas o moleculares de buen rendimiento, ampliamente disponibles que siempre deben solicitarse.
- 9 November 2021
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 69 (4) , E895-E905
Can presence of HLA type I and II alleles be associated with clinical spectrum of CHIKV infection?
Host immune response and virulence factors are key to disease susceptibility. However, there are no known association studies of human leukocyte antigen (HLA) class I and II alleles with chikungunya virus (CHIKV) infection in the Latin American population. Here, we aimed to identify HLA alleles present in patients with CHIKV infection versus healthy controls as well as the allelic association with the clinical spectrum of the disease. We conducted a cross‐sectional analysis of a community cohort and included patients aged 18 years and older with serologically confirmed CHIKV infection. HLA typing of HLA‐A, HLA‐B, and HLA‐DRB1 alleles was performed. Two‐by‐two tables were used to establish associations between allele presence and clinical characteristics. Data from 65 patients with confirmed CHIKV infection were analyzed for HLA typing. CHIKV infection was significantly associated with the presence of HLA‐A*68 [p = .005; odds ratio (OR): 8.90; 95% confidence interval (CI): 1.88–42.13], HLA‐B*35 (p = .03; OR: 2.01; 95% CI: 1.06–3.86), HLA‐DRB*01 (p <.001; OR: 5.70; 95% CI: 1.95–16.59), HLA‐DRB1*04 (p <.001; OR: 7.37; 95% CI: 3.33–16.30), and HLA‐DRB1*13 (p = .004; OR: 3.75; 95% CI: 1.50–9.39) alleles in patients versus healthy subjects. A statistically significant relationship was found between the presence of a rash on the face or abdomen and the presence of HLA‐DRB1*04 (p = .028; OR: 3.2; 95% CI: 1.11–9.15 and p = .007; OR: 4.33; 95% CI: 1.45–12.88, respectively). Our study demonstrated that, in our cohort, HLA type I and type II alleles are associated with CHIKV infection, and an HLA type II allele is associated with dermatological symptoms. Further research is needed to establish a path for future investigation of genes outside the HLA system to improve knowledge of the pathophysiology of CHIKV infection and its host–pathogen interaction.
- 9 November 2021
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 69 (4) , E895-E905
Can presence of HLA type I and II alleles be associated with clinical spectrum of CHIKV infection?
Host immune response and virulence factors are key to disease susceptibility. However, there are no known association studies of human leukocyte antigen (HLA) class I and II alleles with chikungunya virus (CHIKV) infection in the Latin American population. Here, we aimed to identify HLA alleles present in patients with CHIKV infection versus healthy controls as well as the allelic association with the clinical spectrum of the disease. We conducted a cross‐sectional analysis of a community cohort and included patients aged 18 years and older with serologically confirmed CHIKV infection. HLA typing of HLA‐A, HLA‐B, and HLA‐DRB1 alleles was performed. Two‐by‐two tables were used to establish associations between allele presence and clinical characteristics. Data from 65 patients with confirmed CHIKV infection were analyzed for HLA typing. CHIKV infection was significantly associated with the presence of HLA‐A*68 [p = .005; odds ratio (OR): 8.90; 95% confidence interval (CI): 1.88–42.13], HLA‐B*35 (p = .03; OR: 2.01; 95% CI: 1.06–3.86), HLA‐DRB*01 (p <.001; OR: 5.70; 95% CI: 1.95–16.59), HLA‐DRB1*04 (p <.001; OR: 7.37; 95% CI: 3.33–16.30), and HLA‐DRB1*13 (p = .004; OR: 3.75; 95% CI: 1.50–9.39) alleles in patients versus healthy subjects. A statistically significant relationship was found between the presence of a rash on the face or abdomen and the presence of HLA‐DRB1*04 (p = .028; OR: 3.2; 95% CI: 1.11–9.15 and p = .007; OR: 4.33; 95% CI: 1.45–12.88, respectively). Our study demonstrated that, in our cohort, HLA type I and type II alleles are associated with CHIKV infection, and an HLA type II allele is associated with dermatological symptoms. Further research is needed to establish a path for future investigation of genes outside the HLA system to improve knowledge of the pathophysiology of CHIKV infection and its host–pathogen interaction.